Induction of interferon-α and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus

Virology

Volumn 297, Issue 1, 2002, Pages 19-30

  Zeng, Jinyang ^a   Fournier, Philippe ^a   Schirrmacher, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Avian RNA virus; Fusion protein; Hemagglutinin neuraminidase; IFN ; Newcastle disease virus; PBMCs; SFV replicase; TRAIL; Virus cell interactions

Indexed keywords

ALPHA INTERFERON; DNA; HN PROTEIN; HYBRID PROTEIN; PARAFORMALDEHYDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS REPLICASE;

ANIMAL CELL; ARTICLE; BLOOD CELL; CELL MEMBRANE; CELL STRAIN; CELL STRAIN BHK; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA RECOMBINATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOLECULAR BIOLOGY; MONOCYTE; MONONUCLEAR CELL; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE; TIME; ULTRAVIOLET RADIATION; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS REPLICATION;

AVES; NEWCASTLE DISEASE VIRUS; RABBIT FIBROMA VIRUS; RNA VIRUSES; SEMLIKI FOREST VIRUS;

EID: 0036302403     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1413     Document Type: Article

References (54)

1. Interferon induction by HIV glycoprotein 120: Role of the V3 loop
2. Induction of interferon-α by glycoprotein D of herpes simplex virus: A possible role of chemokine receptors
3. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes
4. Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes
5. Interferon alpha inducing property of coronavirus particles and pseudoparticles
6. The neglected role of type I interferon in the T cell response: Implications for its clinical use
7. Severe herpesvirus infections in an adolescent without natural killer cells
8. Recombinant glycoprotein gp120 of human immunodeficiency virus is a potent interferon inducer
9. Newcastle disease virus as an antineoplastic agent
10. Infrequent but efficient interferon-α producing human mononuclear leukocytes induced by herpes simple virus in vitro studied by immuno-plaque and limiting dilution assays
11. Induction of IFN-α by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not viral replication
12. Identification of a novel dendritic cell-like subset of CD64+/CD16+ blood monocytes
13. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine
14. Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus
15. The role of macrophages and macrophage cytokines in host resistance to herpes simplex virus
16. The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: A structural view
17. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: Monoclonal antibodies to some sites prevent viral attachment
18. Components of Sendai virus that can induce interferon in mouse spleen cells
19. Induction of interferon by virus glycoproteins in lymphoid cells through interaction with the cellular receptors via lectin-like action: An alternative interferon induction mechanism
20. HN proteins of human parainfluenza type 4A virus expressed in cell lines transfected with a cloned cDNA have an ability to induce interferon in mouse spleen cells
21. PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus
22. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
23. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
24. Molecular cross-talk between the TRAIL and interferon signalling pathways
25. The lectin neuraminidase inhibition test: A new method for the detection of antibodies to neuraminidase
26. Recognition of hemagglutinin on virus-infected cells by NKp46 activates lysis by human NK cells
27. Substitution of amino acid residue in influenza A virus hemagglutinin affects recognition of sialyl-oligosaccharides containing N-glycolylneuraminic acid
28. The IFN-α-inducing capacity of Sendai virus in human leukocytes is independent from the hemagglutinating and haemolytic activities and from the viral proteins of the Sendai virus preparation
29. Conditions required for induction of interferon by rotaviruses and for their sensitivity to its action
30. Modified Semliki forest virus expression vector that facilitates cloning
31. The mannose receptor mediates induction of IFN-α in peripheral blood dendritic cells by enveloped RNA and DNA viruses
32. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: Upregulated expression by TNF-alpha
33. Molecular biology of Newcastle disease virus
34. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
35. Scientific interest in Newcastle disease virus is reviving
36. Nonopsonic phagocytosis of microorganisms
37. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
38. Limiting dilution analysis of human peripheral blood mononuclear leukocytes that react to human amnion cells and protect against viral challenge
39. Characterization of the blood mononuclear leukocytes producing alpha interferon after stimulation with herpes simplex virus in vitro, by means of combined immunohistochemical staining and in situ RNA-RNA hybridisation
40. A distinct population of nonphagocytic and low level CD4+ null lymphocytes produce IFN-alpha after stimulation by herpes simplex virus-infected cells
41. Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection
42. Immunization with virus-modified tumor cells
43. Tumor stimulator cell modification by infection with Newcastle disease virus: Analysis of effects and mechanism in MLTC-CML cultures
44. Human tumor cell modification by virus infection: An efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
45. Newcastle disease virus activates macrophages for anti-tumor activity
46. The nature of the principal type 1 interferon-producing cells in human blood
47. The cell surface phenotype of human natural interferon-̈ producing cells as determined by flow cytometry
48. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
49. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
50. More than one component of the Newcastle disease virus particle is capable of interferon induction
51. Identification and characterization of a new member of the TNF family that induces apotosis
52. Interferon induction by viruses. VI. Reovirus: Virion genome dsRNA as the interferon inducer in aged chick embryo cells